ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Relay Therapeutics Inc

Relay Therapeutics Inc (RLAY)

6.83
-0.20
(-2.84%)
Closed April 16 4:00PM
6.70
-0.13
(-1.90%)
After Hours: 5:08PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
6.70
Bid
5.00
Ask
9.45
Volume
715,226
6.70 Day's Range 7.1592
5.95 52 Week Range 18.32
Market Cap
Previous Close
7.03
Open
7.04
Last Trade Time
Financial Volume
$ 4,927,387
VWAP
6.8893
Average Volume (3m)
1,154,131
Shares Outstanding
131,179,034
Dividend Yield
-
PE Ratio
-2.62
Earnings Per Share (EPS)
-2.61
Revenue
31.97M
Net Profit
-341.97M

About Relay Therapeutics Inc

Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, i... Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Relay Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RLAY. The last closing price for Relay Therapeutics was $7.03. Over the last year, Relay Therapeutics shares have traded in a share price range of $ 5.95 to $ 18.32.

Relay Therapeutics currently has 131,179,034 shares outstanding. The market capitalization of Relay Therapeutics is $895.95 million. Relay Therapeutics has a price to earnings ratio (PE ratio) of -2.62.

RLAY Latest News

Relay Therapeutics to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining...

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining...

Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

Completed enrollment in initial RLY-2608 600mg + fulvestrant dose expansion cohort & initiated additional dose expansion cohorts with RLY-2608 400mg & 600mg Initiated RLY-2608...

Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024

CAMBRIDGE, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining...

Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.26-3.735632183916.967.386.78547407.09938737CS
4-1.21-15.29709228827.918.436.711791747.50031931CS
12-3.6-34.951456310710.311.166.711541318.909788CS
26-1.05-13.54838709687.7512.145.9511240848.83581965CS
52-10.86-61.845102505717.5618.325.95122386910.03915203CS
156-27.55-80.437956204434.2538.6055.95100867718.09119218CS
260-27.28-80.282519128933.9864.375.9591048420.84213234CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 6.26
(134.46%)
44.34M
LGVNLongeveron Inc
$ 2.94
(73.96%)
57.1M
HUBCHub Cyber Security Ltd
$ 1.9499
(49.99%)
75.08M
SPCBSuperCom Ltd
$ 0.40
(44.93%)
127.58M
ONVOOrganovo Holdings Inc
$ 1.345
(33.16%)
53.79M
MRNSMarinus Pharmaceuticals Inc
$ 1.29
(-82.85%)
35.57M
NXTPNextPlay Technologies Inc
$ 0.20
(-56.52%)
30.41k
CSLRComplete Solaria Inc
$ 0.26
(-50.00%)
814.26k
SWVLSwvl Holdings Corporation
$ 8.10
(-38.96%)
312.72k
MOTSMotus GI Holdings Inc
$ 0.173
(-34.25%)
1.37M
SQQQProShares UltraPro Short QQQ
$ 11.445
(5.10%)
201.04M
SNGXSoligenix Inc
$ 0.4697
(21.65%)
134.51M
SPCBSuperCom Ltd
$ 0.40
(44.93%)
127.58M
NKLANikola Corporation
$ 0.6503
(-7.14%)
121.2M
JAGXJaguar Health Inc
$ 0.109
(20.71%)
115.11M

Your Recent History

Delayed Upgrade Clock